| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.972 | 7.838 | 8.551 | 6.920 | 927 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 4.972 | 7.838 | 8.551 | 6.920 | 927 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 11 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 4.960 | 7.822 | 8.551 | 6.920 | 927 | 0 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | 4.811 | 7.651 | 8.294 | 6.712 | 899 | 0 | 0 | 0 | 0 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Evysmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 16.038 | 23.104 | 31.130 | 37.192 | 37.399 | 36.690 | 35.876 | 35.988 | 35.878 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 0 | -713 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Cash | 16.038 | 23.816 | 31.130 | 37.192 | 37.399 | 36.690 | 35.876 | 35.988 | 35.878 | - |
| Shareholders Funds | 15.607 | 23.098 | 31.002 | 37.145 | 37.325 | 36.617 | 35.805 | 35.916 | 35.807 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 431 | 6 | 128 | 47 | 74 | 73 | 71 | 71 | 71 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8512 - 8512" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Evysmed Srl